In­ter­cep­t's NASH drug is again re­ject­ed by FDA, lead­ing the com­pa­ny to re­struc­ture in piv­ot from dis­ease

In­ter­cept Phar­ma­ceu­ti­cals’ NASH drug obeti­cholic acid was re­ject­ed by the FDA for a sec­ond time on Thurs­day, and the com­pa­ny says it will now dis­con­tin­ue …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER